Table 3.
Clinical Events Over the 2-Year Follow-up
| Outcome | Rate of events over 2 years (%) |
Crude HR | Multivariable aHRA
(95% CI) |
IPW HRB
(95% CI) |
||||
|---|---|---|---|---|---|---|---|---|
| Symptomatic patients |
Asymptomatic patients |
HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
| TVF | 6.5 | 4.9 | 1.38 (0.84–2.26) |
0.20 | 1.61 (0.90–2.86) |
0.11 | 1.50 (0.86–2.62) |
0.15 |
| Cardiac death | 0.35 | 0.29 | 0.75 (0.13–4.48) |
0.75 | 1.47 (0.15–14.3) |
0.74 | 0.91 (0.15–5.61) |
0.92 |
| CDTVR | 6.5 | 4.4 | 1.53 (0.92–2.55) |
0.10 | 1.79 (0.99–3.25) |
0.06 | 1.68 (0.95–2.99) |
0.08 |
| TVMI | 0.35 | 0.33 | 1.13 (0.16–7.99) |
0.91 | 1.91 (0.27–13.7) |
0.62 | 1.22 (0.16–9.12) |
0.84 |
AMultivariable Cox models adjusting for variables indicated in Table 1 and Table 2 as covariates. BUnivariable propensity score-based inverse probability weighted (IPW) Cox models. aHR, adjusted hazard ratio; CDTVR, clinically driven target vessel revascularization; CI, confidence interval; HR, hazard ratio; TVF, target vessel failure.